FDA-Drug2026-04-01Class IIMISBRANDING
Macleods Pharma levothyroxine 150 mcg tablets recalled for subpotent drug
What this means
Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg because they may contain less active ingredient than labeled. This means the medication may not work as intended to treat thyroid conditions. The affected lot is 16240062A with an expiration date of March 2026.
- Stop taking these tablets if you have the affected lot number (16240062A).
- Contact your pharmacy or doctor for a replacement prescription immediately.
- Do not stop your thyroid medication without talking to your doctor first.
- Check your bottle label for lot number 16240062A and NDC 33342-401-44.
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide
Affected count
1315 bottles
Manufactured in
103 College Rd E Fl 2, Princeton, NJ, United States
Products
Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0403-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.